Abbott Wins 'Urgent' Ban On Rival's Glucose Monitor Sales

By Jamie Lennox ( February 20, 2025, 7:04 PM GMT) -- The Unified Patent Court has hit a Chinese company with an interim ban on sales of glucose monitors that may infringe Abbott's patent, citing an "urgent" need for stop-gap measures in a decision released Thursday. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Law360 is pleased to announce the Rising Stars of 2025, our list of more than 150 attorneys under 40 whose legal accomplishments belie their age.